Abemaciclib Approved by FDA for Advanced or Metastatic Breast Cancer

FDA approved abemaciclib (Verzenio™) for the treatment of some people with advanced or metastatic HR-positive, HER2-negative breast cancer whose disease has progressed after treatment with hormone therapy.

Cancer Currents: An NCI Cancer Research Blog